Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national
3
×
national blog main
national top stories
vaccine
3
×
akcea therapeutics
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
covid-19
detroit blog main
detroit top stories
fda
gene therapy
glaxosmithkline
indiana blog main
indiana top stories
medical devices
new york blog main
new york top stories
nonalcoholic steatohepatitis
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2025
abbvie
abcellera
ad-comm
What
bio
cancer
roundup
abbvie’s
abcellera
abcellera’s
ahead
allogene
antibodies
antibody
based
biofourmis
biologics
biotech
bucks
celebrate
chance
corner
coronavirus
crispr
day
days
diversity
enter
forward
holiday
hot
identified
immunotherapy
investors
ipo
juno
labor
leads
looking
medicines
million
nearly
neutralizing
new
Language
unset
Current search:
vaccine
×
national
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More